Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07335315 · ClinicalTrials.gov registry record
Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors
A clinical trial of Pituitary Adenoma and Cushing Disease, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 110
- Enrollment target
- 1
- Study location
NCT07335315 is a study of Pituitary Adenoma and Cushing Disease that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 110 participants, below the 276-participant average among 9 other Pituitary Adenoma trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07335315, a study of Pituitary Adenoma and Cushing Disease, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot and feasibility study aims to combine recent advances in ultrasound imaging, specifically an endonasal transducer array and contrast enhanced ultrasound, to offer an intraoperative image-guided solution for lesion-specific surgical resection to impact clinical outcome. Should this imaging approach help isolate specific lesions and prevent surgical resection of normal pituitary tissue in this first-in-humans study, then the results will provide clinical data for a much larger multi-center clinical trial.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Contrast enhanced pituitary magnetic resonance imaging (MRI)
- DIAGNOSTIC_TEST Contrast enhanced ultrasound
- DIAGNOSTIC_TEST Non-Contrast Ultrasound
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2024-06-19 |
| Est. Completion | 2027-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07335315
The ClinicalTrials.gov registry entry for NCT07335315 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 276-participant average among 9 other Pituitary Adenoma trials with a reported enrollment target (60% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pituitary Adenoma appearing as the primary indexed condition, and to 3 interventions - of which Contrast enhanced pituitary magnetic resonance imaging (MRI) is the first listed.
NCT07335315 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT07335315 about?
NCT07335315 is a clinical study titled "Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors". This pilot and feasibility study aims to combine recent advances in ultrasound imaging, specifically an endonasal transducer array and contrast enhanced ultrasound, to offer an intraoperative image-guided solution for lesion-specific surgical resection to impact clinical outcome. Should this imaging...
What is the current status of trial NCT07335315?
This trial is currently recruiting. The enrollment target is 110 participants. The study started on 2024-06-19. Estimated completion is 2027-01.
What conditions does trial NCT07335315 study?
This clinical trial studies the following conditions: Pituitary Adenoma, Cushing Disease.
What interventions are being tested in trial NCT07335315?
The interventions under investigation include: Contrast enhanced pituitary magnetic resonance imaging (MRI) (DIAGNOSTIC_TEST), Contrast enhanced ultrasound (DIAGNOSTIC_TEST), Non-Contrast Ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07335315?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07335315 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pituitary Adenoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
RECRUITING · Phase 4
-
DDAVP for Pituitary Adenoma
RECRUITING · NA
-
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
RECRUITING · Phase 4
-
Use of [18F] Fluoroethyl-L-tyrosine PET/MRI for Identifying Small Functional Pituitary Adenomas
RECRUITING · Phase 1
-
A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors
ACTIVE NOT RECRUITING · Phase 1
-
Surgical Debulking of Pituitary Adenomas
COMPLETED · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.